Vivalytic SARS-CoV-2 rapid PCR test
With over 80 million cases and 1.7 million deaths reported worldwide by the end of 2020 alone, COVID-19 poses major challenges for the healthcare system and our society in general. In order to efficiently prevent the rapid spread of the SARS-CoV‑2 virus, infection chains must be quickly identified and stopped – this is where the Vivalytic rapid PCR test helps.
The SARS coronavirus 2 (SARS-CoV‑2) is a respiratory pathogen which is responsible for the novel disease COVID-19. The infection emerged for the first time in the final months of 2019 and has since developed into a global pandemic. With over 10 million cases and 500,000 deaths reported as of end of June 2020 [1] , COVID-19 is challenging health care systems and society all over the world.
As we start to return to as much normality in everyday life as possible, it is important not only to have effective infection-preventing measures in place, but also to trace the chains of infection through extensive testing. To this end, the Vivalytic SARS-CoV‑2 test provides a fast and reliable solution directly at the point of care.
- Center for Systems Science and Engineering (CSSE)
at Johns Hopkins University
Respiratory infections
- SARS-CoV‑2
Product Specifications
|
Sample Type |
Nasopharyngeal and/or oropharyngeal swab |
|---|---|
|
Sample Input Volume |
300µl |
|
Reagent Storage Conditions |
15 – 25 °C |
|
|
|
Ordering Information
|
Product |
Pack size |
Order number |
|---|---|---|
|
Vivalytic SARS-CoV‑2 |
15 cartridges |
V1012 |